These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 29669324)
41. MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip. Gao L; Yan SB; Yang J; Kong JL; Shi K; Ma FC; Huang LZ; Luo J; Yin SY; He RQ; Hu XH; Chen G BMC Med Genomics; 2020 Jan; 13(1):3. PubMed ID: 31906958 [TBL] [Abstract][Full Text] [Related]
42. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer. Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784 [TBL] [Abstract][Full Text] [Related]
43. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance. Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608 [TBL] [Abstract][Full Text] [Related]
44. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis. Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858 [TBL] [Abstract][Full Text] [Related]
45. Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer. Zhu W; He J; Chen D; Zhang B; Xu L; Ma H; Liu X; Zhang Y; Le H PLoS One; 2014; 9(2):e87780. PubMed ID: 24523873 [TBL] [Abstract][Full Text] [Related]
46. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer. Sun B; Liu HF; Ding Y; Li Z Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA-377 inhibits non-small-cell lung cancer through targeting AEG-1. Meng F; Zhang L; Shao Y; Ma Q; Lv H Int J Clin Exp Pathol; 2015; 8(11):13853-63. PubMed ID: 26823698 [TBL] [Abstract][Full Text] [Related]
48. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer. Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047 [TBL] [Abstract][Full Text] [Related]
49. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database. Ke D; Guo Q; Fan TY; Xiao X Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657 [No Abstract] [Full Text] [Related]
50. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival. Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777 [TBL] [Abstract][Full Text] [Related]
51. Identification of miR-210 and combination biomarkers as useful agents in early screening non-small cell lung cancer. Hu X; Peng Q; Zhu J; Shen Y; Lin K; Shen Y; Zhu Y Gene; 2020 Mar; 729():144225. PubMed ID: 31830514 [TBL] [Abstract][Full Text] [Related]
52. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer. Feng A; Tu Z; Yin B Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258 [TBL] [Abstract][Full Text] [Related]
53. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
54. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer. Zhu J; Zhang Y; Yang X; Jin L Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208 [TBL] [Abstract][Full Text] [Related]
55. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer. Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507 [TBL] [Abstract][Full Text] [Related]
56. Anti-NSCLC role of SCN4B by negative regulation of the cGMP-PKG pathway: Integrated utilization of bioinformatics analysis and in vitro assay validation. Yang X; Liu Q; Li G Drug Dev Res; 2024 May; 85(3):e22192. PubMed ID: 38678552 [TBL] [Abstract][Full Text] [Related]
57. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc. Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966 [TBL] [Abstract][Full Text] [Related]
58. Low serum miR-98 as an unfavorable prognostic biomarker in patients with non-small cell lung cancer. Wang K; Dong L; Fang Q; Xia H; Hou X Cancer Biomark; 2017 Sep; 20(3):283-288. PubMed ID: 28946561 [TBL] [Abstract][Full Text] [Related]
59. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096 [TBL] [Abstract][Full Text] [Related]
60. Predictive value of microRNA-10b expression in peripheral blood mononuclear cells in evaluating short- and long-term efficacy of chemotherapy for patients with advanced non-small-cell lung cancer. Yang YL; Wang W; Xu LP Neoplasma; 2018; 65(4):610-619. PubMed ID: 30064233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]